Detalles de la búsqueda
1.
The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study.
BMC Health Serv Res
; 23(1): 513, 2023 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210502
2.
Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.
Clin Infect Dis
; 74(7): 1183-1190, 2022 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34251436
3.
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Value Health
; 24(12): 1828-1834, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838281
4.
Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe.
Clin Infect Dis
; 71(8): 1994-1999, 2020 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060511
5.
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.
Lancet
; 403(10422): e2-e4, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774936
6.
Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral Action.
Clin Infect Dis
; 68(11): 1952-1959, 2019 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30256927
7.
Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
Clin Infect Dis
; 65(8): 1378-1382, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017240
8.
International cooperation to improve access to and sustain effectiveness of antimicrobials.
Lancet
; 387(10015): 296-307, 2016 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26603920
9.
An antibiotic's journey from marketing authorization to use, Norway.
Bull World Health Organ
; 95(3): 220-226, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28250535
10.
Adapting environmental surveillance for polio to the need to track antimicrobial resistance.
Bull World Health Organ
; 99(3): 239-240, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33716347
11.
Supply chain transparency and the availability of essential medicines.
Bull World Health Organ
; 99(4): 319-320, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33953450
12.
Financing and collaboration on research and development for nodding syndrome.
Health Res Policy Syst
; 14: 19, 2016 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26983551
13.
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
Lancet
; 382(9900): 1286-307, 2013 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23697824
14.
Availability of essential, generic medicines before and during COVID-19 at selected public pharmaceutical supply agencies in Ethiopia: a comparative cross-sectional study.
BMJ Open
; 14(3): e077545, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443082
15.
Common characteristics of open source software development and applicability for drug discovery: a systematic review.
Health Res Policy Syst
; 9: 36, 2011 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21955914
16.
National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation.
Antibiotics (Basel)
; 10(6)2021 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34205554
17.
The effect of generic market entry on antibiotic prescriptions in the United States.
Nat Commun
; 12(1): 2937, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006862
18.
Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis.
Antimicrob Resist Infect Control
; 9(1): 142, 2020 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32831153
19.
A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies.
JAC Antimicrob Resist
; 2(2): dlaa034, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34222996
20.
A one health framework to estimate the cost of antimicrobial resistance.
Antimicrob Resist Infect Control
; 9(1): 187, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33243302